U.S. FTC says approves final order settling charges related to DaVita-Renal Ventures deal
June 14 (Reuters) - U.S. Federal Trade Commission::Approved final order settling charges that DaVita Inc’s acquisition of Renal Ventures Management would have been anticompetitive.
Latest Developments forDaVita Inc
Latest Key Developments inHealthcare
- UnitedHealth Among Suitors Exploring Acquisition Of Tenet Healthcare Corp's Health-Care-Management Subsidiary - WSJ
- Nxstage Medical Inc Says Co Agreed To Sell Its Bloodlines Business
- Community Health Announces Agreement To Sell Sparks Health System
- Tenet Announces Agreement With Pipeline Health And TWG Partners On Sale Of Co's Chicago Hospitals